Determination of permeability, plasma protein binding, blood partitioning, pharmacokinetics and tissue distribution of Withanolide A in rats: A neuroprotective steroidal lactone
- 4 October 2018
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 79 (7) , 339-351
Abstract
Preclinical Research & Development Withanolide A (WA), a steroidal lactone is a major bioactive constituent of Withania somnifera (L.) with remarkable neuropharmacological activity. In this study, we investigated the permeability, plasma protein binding (PPB), blood partitioning, intravenous (i.v.), and oral pharmacokinetics as well as i.v. tissue distribution (TD) of pure WA in a rat model. The PPB, RBCs partitioning, and permeability of WA were determined by Ultra Performance Liquid Chromatography (UPLC) method. However, the pharmacokinetics and TD of WA were evaluated by validated and sensitive liquid chromatography coupled mass spectrometry (LC‐ESI‐MS/MS) method. The PPB and permeability of WA were determined by equilibrium dialysis and parallel artificial membrane permeability assay method, respectively. The results demonstrated that WA has high PPB and passive permeability. Furthermore, WA was found to have fast equilibration between RBCs and plasma. Following i.v. (2 mg/kg) and per‐oral (25 mg/kg) administration of WA, the max concentration (Cmax) in plasma was found as 85.53 ± 6.54 and 48.04 ±5.78 ng/mL, respectively. The TD study results indicated that WA has a rapid and wide TD. The maximum concentration in various tissues was found in following order: Clung > Cliver > Ckidney ≈ Cspleen > Cheart > Cbrain. The preclinical in vitro, as well as pharmacokinetics and TD results, are anticipated to support the future preclinical and clinical application of WA.Keywords
Funding Information
- Department of Biotechnology
- University Grants Commission
- Council of Scientific and Industrial Research
This publication has 43 references indexed in Scilit:
- Quantitative determination of multi markers in five varieties of Withania somnifera using ultra-high performance liquid chromatography with hybrid triple quadrupole linear ion trap mass spectrometer combined with multivariate analysis: Application to pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2016
- Withanolide A offers neuroprotection, ameliorates stress resistance and prolongs the life expectancy of Caenorhabditis elegansExperimental Gerontology, 2016
- Neuro-protective potential of a vesicular system of a standardized extract of a new chemotype of Withania somnifera Dunal (NMITLI118RT+) against cerebral stroke in ratsDrug Delivery, 2015
- Pharmacokinetics and tissue distribution study of novel potent antiplatelet agent S007-867 in mice using HPLC-MS/MSXenobiotica, 2014
- Withanolide A Prevents Neurodegeneration by Modulating Hippocampal Glutathione Biosynthesis during HypoxiaPLOS ONE, 2014
- Evaluation of Anti-inflammatory Effect of Ashwagandha: A Preliminary Study in vitroPharmacognosy Journal, 2012
- Comparison of the Pharmacokinetics of Hawthorn Phenolics in Extract Versus Individual Pure CompoundThe Journal of Clinical Pharmacology, 2005
- Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammationJournal of Ethnopharmacology, 1999
- Antistressor effect of Withania somniferaJournal of Ethnopharmacology, 1998
- Semi-quantitative reversed-phase high-performance liquid chromatographic analysis of the ecotypes of withania somnifera chemotype IIIJournal of Chromatography A, 1987